TYRUKO (natalizumsb-sztn)

• TYRUKO (natalizumsb-sztn)

  Biosimilar to Tysabri. IV infusions every 4 weeks.

• Topics

• Tyruko--first biosimilar to treat MS--now available

  Started by agate on 17 Nov, 2025 15:25

  Views: 23, Replies: 0

• Possible adverse side effects found after switch from Tysabri to Tyruko

  Started by agate on 24 Feb, 2025 20:34

  Views: 90, Replies: 0

• FDA-approved Tyruko (natalizumab-sztn)

  Started by agate on 26 Aug, 2024 20:47
  Last post by agate on 26 Aug, 2024 20:59

  Views: 200, Replies: 1